The Biomedical Engineering and Advanced Manufacturing (BEAM) centre is located in McMaster Innovation Park in Hamilton, Ontario, Canada.
22 March 2018 projects
22 February 2018 Comment
GlobalData projects the total revenue from branded infectious diseases (ID) drugs and vaccines to surpass $75bn in 2017.
18 September 2017
Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases, in particular...
19 June 2017
In recent years emerging markets are gaining precedence in the pharmaceutical industry.
27 February 2014 projects
The Public Health Agency of Canada (PHAC) opened a new infectious diseases research centre at 745 Logan Avenue in the Winnipeg city of Manitoba province, Canada, in February 2014.
7 January 2014
Japanese pharmaceutical firm Astellas Pharma has entered into a strategic partnership with ClearPath Development Company to form a portfolio of development companies focused on producing vaccines for infectious diseases.
27 March 2013 Analysis
British scientists have developed a way to create an entirely synthetic vaccine, eliminating the need to rely on dangerous live infectious virus, making the process much safer.
12 February 2013
A specialised centre focusing on the development of drugs for infectious diseases commonly found in developing countries, such as tuberculosis (TB) and malaria, is to be set up by The...
12 September 2010
US biopharmaceutical firms currently have 395 drugs and vaccines to fight infectious diseases in clinical trials or under review by the US Food and Drug Administration, according to a report...